(S1 (S (NP (NP (DT A) (JJ new) (NN drug)) (SBAR (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN rejection)) (PP (IN of) (NP (VBN transplanted) (NNS organs))))))))) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB successfully)) (VBN used) (PP (IN on) (NP (NP (QP (JJR more) (IN than) (CD 100)) (NNS patients)) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh))))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NNS researchers))))))) (. .)))

(S1 (S (S (NP (NP (DT The) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB still)) (PP (IN in) (NP (DT the) (JJ experimental) (NN phase)))))) (, ,)) (VP (VBZ has) (RB n't) (VP (VBN been) (VP (VBN approved) (ADVP (RB yet)) (PP (IN by) (NP (DT the) (NNP Food) (CC and) (NNP Drug) (NNP Admistration))))))) (, ,) (CC and) (S (NP (PRP$ its) (JJ long-term) (NNS effects)) (VP (VBP are) (ADJP (JJ unknown)))) (. .)))

(S1 (S (CC But) (NP (NNS researchers)) (VP (VBP say) (SBAR (S (NP (NP (DT the) (NN drug)) (, ,) (VP (VBN called) (S (NP (NNP FK-506)))) (, ,)) (VP (MD could) (VP (VB revolutionize) (NP (DT the) (NN transplantation) (NN field)) (PP (PP (IN by) (S (VP (VBG reducing) (NP (JJ harmful) (NN side) (NNS effects))))) (CC and) (PP (IN by) (S (VP (VBG lowering) (NP (NN rejection) (NNS rates))))))))))) (. .)))

(S1 (S (NP (NN Rejection)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT the) (JJ major) (NN obstacle)) (PP (IN in) (NP (NP (DT the) (QP (RB approximately) (CD 30,000)) (NN organ) (NNS transplants)) (VP (VBN performed) (NP (ADVP (RB world-wide)) (DT each) (NN year)))))))) (. .)))

(S1 (S (NP (NNS Researchers)) (VP (VBD began) (S (VP (VBG using) (NP (DT the) (NN drug)))) (PP (IN in) (NP (NNP February))) (PP (IN on) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NN kidney) (, ,) (NN liver) (, ,) (NN heart) (CC and) (NNS pancreas) (NNS transplants))))))))) (. .)))

(S1 (S (NP (NP (RB Only) (CD two)) (PP (IN of) (NP (CD 111) (NNS transplants)))) (VP (VBP have) (VP (VBN been) (VP (VBN rejected)))) (. .)))

(S1 (S (NP (NP (DT The) (NN drug)) (, ,) (VP (VBN discovered) (PP (IN in) (NP (CD 1984)))) (, ,)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN from) (NP (NP (NN soil) (NNS fungus)) (VP (VBN found) (PP (IN in) (NP (NNP Japan)))))))) (. .)))

(S1 (S (NP (DT The) (NNP Pittsburgh) (NNS patients)) (VP (VBP are) (NP (NP (DT the) (JJ first) (NNS humans)) (SBAR (S (VP (TO to) (VP (VB be) (PP (VBN given) (NP (NP (DT the) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN made) (PP (IN by) (NP (NNP Fujisawa) (NNP Pharmaceutical) (NNP Co))))))))))))))) (. .)))

(S1 (SINV (`` `) (S (`` `) (NP (PRP We)) (VP (VBP 're) (VP (VBN shocked) (PP (IN by) (NP (PRP it))) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ 's) (VP (VBN worked) (ADVP (RB so) (RB fast))))))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (NNP Dr.) (NNP Thomas) (NNP E.) (NNP Starzl)) (, ,) (NP (NP (NN director)) (PP (IN of) (NP (DT the) (NAC (NNP University) (PP (IN of) (NP (NNP Pittsburgh)))) (NN Transplantation) (NN Program))))) (, ,) (PP (IN at) (NP (NP (DT a) (NN news) (NN conference)) (ADVP (RB here)) (NP (NN yesterday)))) (. .)))

(S1 (SINV (`` `) (S (`` `) (NP (PRP We)) (VP (VBP consider) (NP (PRP it)) (NP (DT a) (JJ life-saving) (NN drug)) (, ,) (PP (IN like) (NP (NP (CD one)) (PP (IN for) (NP (NNP AIDS)))))) (, ,) ('' ')) ('' ') (VP (VBD said)) (NP (NP (NNP Dr.) (NNP John) (NNP Fung)) (, ,) (NP (NP (DT an) (NN immunologist)) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh))))))) (. .)))

(S1 (S (NP (NNS Researchers)) (VP (VBP say) (SBAR (S (NP (PRP they)) (VP (VBP believe) (SBAR (S (NP (CD FK-506)) (VP (VBZ is) (ADJP (ADVP (NP (CD 100) (NNS times)) (RBR more)) (JJ effective) (PP (IN than) (NP (NP (DT the) (JJ traditional) (NN anti-rejection) (NN drug) (, ,) (NN cyclosporine) (, ,)) (VP (VBN made) (PP (IN by) (NP (JJ Swiss) (JJ pharmaceutical) (NN giant) (NNP Sandoz) (NNP Ltd)))))))))))))) (. .)))

(S1 (S (NP (PRP They)) (VP (VBP are) (ADVP (RB also)) (VP (VBN encouraged) (PP (IN by) (NP (NP (DT the) (ADJP (RB relatively) (JJ mild)) (NN side) (NNS effects)) (PP (IN of) (NP (CD FK-506))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NN cyclosporine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB cause) (NP (UCP (NP (JJ renal) (NN failure)) (, ,) (NN morbidity) (, ,) (NN nausea) (CC and) (JJ other)) (NNS problems))))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (NP (DT The) (NN side) (NNS effects)) (-LRB- -LCB-) (PP (IN of) (NP (NN cyclosporine))) (-RRB- -RCB-)) (VP (VBP have) (VP (VBN made) (NP (DT the) (NN penalty)) (PP (IN for) (NP (NP (PRP$ its) (NN success)) (ADJP (RB rather) (JJ high)))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said)) (. .)))

(S1 (S (NP (NNP Dr.) (NNP Fung)) (VP (VBD said) (SBAR (SBAR (IN that) (S (NP (CD FK-506)) (VP (MD would) (RB not) (VP (VB be) (ADJP (JJ available) (PP (IN in) (NP (NP (DT the) (NN market)) (PP (IN for) (NP (ADVP (IN at) (JJS least)) (DT a) (NN year)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT the) (NNP FDA) (NN approval) (NN process)) (ADVP (RB usually)) (VP (VBZ takes) (NP (CD three) (NNS years)) (PP (TO to) (NP (CD five) (NNS years)))))))) (. .)))

(S1 (S (NP (EX There)) (VP (VBP are) (NP (DT no) (JJ firm) (NNS plans) (S (VP (TO to) (VP (VB expand) (NP (DT the) (JJ experimental) (NN program)) (PP (IN beyond) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh))) (, ,) (SBAR (WHNP (WP$ whose) (NN hospital)) (S (VP (VBZ performs) (NP (NP (DT the) (JJS most) (NNS transplants)) (PP (IN in) (NP (DT the) (NN world)))))))))))))) (. .)))

(S1 (S (S (NP (NNS Researchers)) (VP (MD could) (RB n't) (VP (VB estimate) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (DT the) (NN drug)))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ reaches) (NP (DT the) (NN market)))))))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBD said) (SBAR (S (NP (CD FK-506)) (VP (MD will) (VP (VB enable) (S (NP (NNS patients)) (VP (TO to) (VP (VP (VB cut) (NP (NN hospital) (NNS stays)) (PP (IN by) (NP (CD 50) (NN %)))) (CC and) (VP (VB reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN blood) (NNS tests)) (VP (VBN used) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (UCP (NN cyclosporine) (CC and) (JJ other)) (NNS drugs)))) (PP (IN among) (NP (NN transplant) (NNS recipients)))))))))))))))))))) (. .)))

(S1 (S (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said) (SBAR (SBAR (S (NP (DT the) (NN research)) (VP (VBZ has) (VP (VBN been) (ADVP (RB largely)) (VP (VBN financed) (PP (PP (IN by) (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health))))) (CC and) (PP (IN by) (NP (NN university) (NNS funds))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NNP Fujisawa)) (VP (VBD did) (RB n't) (VP (VB give) (NP (DT the) (NN hospital)) (NP (DT any) (NNS grants)))))))) (. .)))

(S1 (S (NP (PRP He)) (VP (VBD said) (SBAR (IN that) (S (NP (DT the) (NN research) (NN team)) (VP (VBD had) (NP (NP (DT no) (JJ financial) (NN stake)) (PP (IN in) (NP (DT the) (NN drug)))))))) (. .)))

(S1 (S (`` `) (S (S (`` `) (NP (PRP We)) (VP (VBP 've) (VP (VBN known) (PP (IN for) (NP (NP (NP (CD six) (NNS months)) (NP (DT the) (NN effect))) (PP (IN of) (NP (DT this) (NN drug)))))))) (, ,) (CC and) (S (NP (NP (PRP$ our) (NN advice)) (PP (TO to) (NP (PRP$ our) (NNS people)))) (VP (VBZ has) (VP (VBN been) (S (RB not) (VP (TO to) (VP (VB buy) (NP (NP (DT the) (NN company) (POS 's)) (NN stock))))))))) (, ,) ('' ') ('' ') (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said) (, ,) (S (VP (VBG adding) (SBAR (IN that) (S (S (VP (VBG profiting) (PP (IN from) (NP (CD FK-506))))) (VP (MD would) (RB n't) (VP (VB be) (ADJP (JJ ethical))))))))) (. .)))

